Response to new drug in patients with lymphomas and advanced solid tumors
Patients with B-cell Non-Hodgkin lymphomas and advanced solid tumours have responded to a new drug that is being tested for the first time in humans in a phase I clinical trial.
Nov 20, 2014
0
0